With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.
Global Blood Therapeutics (GBT) intends to improve access to high-quality healthcare for people with sickle cell disease (SCD) in the U.S. through the recently launched Access to Excellent Care for Sickle ... Read more
The blood-separation device Spectra Optia, which has the ability to remove abnormal red blood cells from sickle cell patients, can efficiently and safely replace these cells with healthy red blood cells from ... Read more
McKesson Plasma and Biologics LLC will distribute Endari, a therapy indicated to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients age 5 and older. ... Read more
Hoffmann-La Roche has sold the worldwide rights to its discontinued heart disease drug, inclacumab, to Global Blood Therapeutics (GBT) for $2 million and milestone payments. GBT plans to investigate inclacumab as a ... Read more
The Sickle Cell Foundation of Georgia (SCFG) has partnered with Biotech Research Laboratories and the Phoenix Tears Foundation to raise money for the first clinical study focused on the effectiveness ... Read more
Researchers used a gene editing tool to insert mutations into blood cells to increase their production of fetal hemoglobin, which may advance the development of new therapies for sickle cell ... Read more
Despite an increased risk of invasive pneumococcal disease (IPD) in children with sickle cell anemia (SCA), preventive treatment (prophylaxis) rates remain low among these patients, a study shows. The research, “Antibiotic ... Read more